Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Wilmington, DE
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Wilmington, DE
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Washington,
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Washington,
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Jacksonville, FL
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Boise, ID
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Boise, ID
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigator Site
mi
from
Chicago, IL
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigator Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
St. Louis, MO
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
St. Louis, MO
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Morristown, NJ
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Morristown, NJ
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis
mi
from
New York, NY
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis
mi
from
New York, NY
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Toledo, OH
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Toledo, OH
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Oklahoma City, OK
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Oklahoma City, OK
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis
mi
from
Portland, OR
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis
mi
from
Portland, OR
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Philadelphia, PA
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Sioux Falls, SD
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Nashville, TN
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Houston, TX
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigative Site
mi
from
Richmond, VA
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigative Site
mi
from
Richmond, VA
Click here to add this to my saved trials
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated:  10/3/2014
Novartis Investigator Site
mi
from
Milwaukee, WI
Study to Validate the Instructions for Use of TOBI® Podhaler™ in Cystic Fibrosis Patients
A Multi-center, Human Factors Engineering (HFE) Usability Study in Cystic Fibrosis Patients to Validate the Approved Instructions for Use (IFU) of TOBI® Podhaler™ (Tobramycin Inhalation Powder) Using Placebo Capsules
Status: Enrolling
Updated: 10/3/2014
Novartis Investigator Site
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients
Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients
Status: Enrolling
Updated:  10/17/2014
University of California at San Francisco
mi
from
San Francisco, CA
Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients
Short Term Effects of Ivacaftor in Non-G551D Cystic Fibrosis Patients
Status: Enrolling
Updated: 10/17/2014
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Chest Ultrasound of ER Patients With Cough or SOB
Prospective Evaluation With Ultrasound of Emergency Department Patients Presenting With Cough or Dyspnea
Status: Enrolling
Updated:  10/17/2014
University of Washington Medical Center
mi
from
Seattle, WA
Chest Ultrasound of ER Patients With Cough or SOB
Prospective Evaluation With Ultrasound of Emergency Department Patients Presenting With Cough or Dyspnea
Status: Enrolling
Updated: 10/17/2014
University of Washington Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Fetal Tracheal Balloon Study in Diaphragmatic Hernia
Phase 2 Fetal Tracheal Balloon (IDE G080077) Study in Diaphragmatic Hernia
Status: Enrolling
Updated:  11/4/2014
Rhode Island Hospital/Women & Infants' Hospital of Rhode Island
mi
from
Providence, RI
Fetal Tracheal Balloon Study in Diaphragmatic Hernia
Phase 2 Fetal Tracheal Balloon (IDE G080077) Study in Diaphragmatic Hernia
Status: Enrolling
Updated: 11/4/2014
Rhode Island Hospital/Women & Infants' Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis
Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis
Status: Enrolling
Updated:  11/24/2014
University of Michigan
mi
from
Ann Arbor, MI
Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis
Exploring Novel Interventions to Improve Adherence in Children With Cystic Fibrosis
Status: Enrolling
Updated: 11/24/2014
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Effect of Interscalene Block on Obstructive Sleep Apnea in Shoulder Surgery Patients
Influence of Inter-scalene Blockade on Postoperative Episodic Desaturation in Patients at High Risk of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  12/4/2014
Domino's Farm's Preoperative Clinic
mi
from
Ann Arbor, MI
Effect of Interscalene Block on Obstructive Sleep Apnea in Shoulder Surgery Patients
Influence of Inter-scalene Blockade on Postoperative Episodic Desaturation in Patients at High Risk of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 12/4/2014
Domino's Farm's Preoperative Clinic
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Effect of Interscalene Block on Obstructive Sleep Apnea in Shoulder Surgery Patients
Influence of Inter-scalene Blockade on Postoperative Episodic Desaturation in Patients at High Risk of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  12/4/2014
University of Michigan Hospitals
mi
from
Ann Arbor, MI
Effect of Interscalene Block on Obstructive Sleep Apnea in Shoulder Surgery Patients
Influence of Inter-scalene Blockade on Postoperative Episodic Desaturation in Patients at High Risk of Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 12/4/2014
University of Michigan Hospitals
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  12/8/2014
University of Southern California
mi
from
Los Angeles, CA
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 12/8/2014
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  12/8/2014
University of Minnesota - Cystic Fibrosis Center
mi
from
Minneapolis, MN
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 12/8/2014
University of Minnesota - Cystic Fibrosis Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Status: Enrolling
Updated:  12/8/2014
University of Utah
mi
from
Salt Lake City, UT
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis
Status: Enrolling
Updated: 12/8/2014
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model
Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model
Status: Enrolling
Updated:  12/8/2014
Moses Taylor Hospital
mi
from
Scranton, PA
Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model
Improving Medication Adherence Through a Transitional Care Pharmacy Practice Model
Status: Enrolling
Updated: 12/8/2014
Moses Taylor Hospital
mi
from
Scranton, PA
Click here to add this to my saved trials
Safety Study of Inhaled Saline in Acute Lung Injury
Inhaled Hypertonic Saline for the Treatment of Acute Lung Injury
Status: Enrolling
Updated:  12/11/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Safety Study of Inhaled Saline in Acute Lung Injury
Inhaled Hypertonic Saline for the Treatment of Acute Lung Injury
Status: Enrolling
Updated: 12/11/2014
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Study to Assess Stairs as an Outcome Measure in Individuals With Pulmonary Disease
Study to Assess if Ability to Ascend and Descend Stairs Within 30 Seconds Will Prove to be a Reliable and Valid Outcome Measure in Individuals With Pulmonary Disease
Status: Enrolling
Updated:  12/29/2014
Beth Israel Med Ctr
mi
from
New York, NY
Study to Assess Stairs as an Outcome Measure in Individuals With Pulmonary Disease
Study to Assess if Ability to Ascend and Descend Stairs Within 30 Seconds Will Prove to be a Reliable and Valid Outcome Measure in Individuals With Pulmonary Disease
Status: Enrolling
Updated: 12/29/2014
Beth Israel Med Ctr
mi
from
New York, NY
Click here to add this to my saved trials
To Evaluate Effects of GSK2256294 on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions
A Randomised Placebo-controlled Study to Evaluate the Effects of GSK2256294 Following Repeat Dosing on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions
Status: Enrolling
Updated:  1/15/2015
GSK Investigational Site
mi
from
Baltimore, MD
To Evaluate Effects of GSK2256294 on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions
A Randomised Placebo-controlled Study to Evaluate the Effects of GSK2256294 Following Repeat Dosing on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions
Status: Enrolling
Updated: 1/15/2015
GSK Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
Impact of Swaddle Blanket on Gastroesophageal Reflux
Impact of Swaddle Blanket on Gastroesophageal Reflux
Status: Enrolling
Updated:  1/19/2015
The Valley Hospital
mi
from
Ridgewood, NJ
Impact of Swaddle Blanket on Gastroesophageal Reflux
Impact of Swaddle Blanket on Gastroesophageal Reflux
Status: Enrolling
Updated: 1/19/2015
The Valley Hospital
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Modafinil, Sleep Architecture and Cocaine Relapse
Modafinil, Sleep Architecture and Cocaine Relapse
Status: Enrolling
Updated:  1/21/2015
Connecticut Mental Health Center
mi
from
New Haven, CT
Modafinil, Sleep Architecture and Cocaine Relapse
Modafinil, Sleep Architecture and Cocaine Relapse
Status: Enrolling
Updated: 1/21/2015
Connecticut Mental Health Center
mi
from
New Haven, CT
Click here to add this to my saved trials
Respiratory Disease Management
Use of a Respiratory Care Practitioner Disease Management (RCP-DM) Program for Patients Hospitalized With COPD
Status: Enrolling
Updated:  1/26/2015
Barnes Jewish Hospital
mi
from
St. Louis, MO
Respiratory Disease Management
Use of a Respiratory Care Practitioner Disease Management (RCP-DM) Program for Patients Hospitalized With COPD
Status: Enrolling
Updated: 1/26/2015
Barnes Jewish Hospital
mi
from
St. Louis, MO
Click here to add this to my saved trials
Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers
A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, 4-Period Crossover Study to Evaluate the Effect of GSK2140944 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
Status: Enrolling
Updated:  1/26/2015
GSK Investigational Site
mi
from
Austin, TX
Placebo and Moxifloxacin Controlled Cardiac Conduction Study of GSK2140944 in Healthy Volunteers
A Phase I, Randomized, Double-Blinded, Placebo- and Moxifloxacin-Controlled, 4-Period Crossover Study to Evaluate the Effect of GSK2140944 on Cardiac Conduction as Assessed by 12-lead Electrocardiogram in Healthy Volunteers
Status: Enrolling
Updated: 1/26/2015
GSK Investigational Site
mi
from
Austin, TX
Click here to add this to my saved trials
Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients
Pilot Trial of Phototherapy for Acute Depression in Hospitalized CF Patients
Status: Enrolling
Updated:  2/2/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Pilot Trial of Phototherapy for Acute Depression in Hospitalized Cystic Fibrosis Patients
Pilot Trial of Phototherapy for Acute Depression in Hospitalized CF Patients
Status: Enrolling
Updated: 2/2/2015
Nationwide Children's Hospital
mi
from
Columbus, OH
Click here to add this to my saved trials
Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading
Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading
Status: Enrolling
Updated:  4/6/2015
Massachusetts General Hospital
mi
from
Boston, MA
Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading
Impact of PAV Versus NAVA on Patient-Ventilator Synchrony and Respiratory Muscle Unloading
Status: Enrolling
Updated: 4/6/2015
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Registry of COPD Patients to be Used for Future Studies
The Ohio State University COPD Registry
Status: Enrolling
Updated:  4/20/2015
Ohio State University
mi
from
Columbus, OH
A Registry of COPD Patients to be Used for Future Studies
The Ohio State University COPD Registry
Status: Enrolling
Updated: 4/20/2015
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Pharmacologic MRI in Cocaine Addiction
Pharmacologic MRI in Cocaine-addiction
Status: Enrolling
Updated:  5/29/2015
UT Southwestern Medical Center at Dallas, Divison on Addictions
mi
from
Dallas, TX
Pharmacologic MRI in Cocaine Addiction
Pharmacologic MRI in Cocaine-addiction
Status: Enrolling
Updated: 5/29/2015
UT Southwestern Medical Center at Dallas, Divison on Addictions
mi
from
Dallas, TX
Click here to add this to my saved trials
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  6/1/2015
205.452.01060 Boehringer Ingelheim Investigational Site
mi
from
Winter Park, FL
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 6/1/2015
205.452.01060 Boehringer Ingelheim Investigational Site
mi
from
Winter Park, FL
Click here to add this to my saved trials
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  6/1/2015
1199.14.1261 Boehringer Ingelheim Investigational Site
mi
from
Skokie, IL
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 6/1/2015
1199.14.1261 Boehringer Ingelheim Investigational Site
mi
from
Skokie, IL
Click here to add this to my saved trials
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  6/1/2015
205.440.1017 Boehringer Ingelheim Investigational Site
mi
from
Muncie, IN
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 6/1/2015
205.440.1017 Boehringer Ingelheim Investigational Site
mi
from
Muncie, IN
Click here to add this to my saved trials
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  6/1/2015
1199.15.10103 Boehringer Ingelheim Investigational Site
mi
from
Minneapolis, MN
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 6/1/2015
1199.15.10103 Boehringer Ingelheim Investigational Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  6/1/2015
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 6/1/2015
Boehringer Ingelheim Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  6/1/2015
Boehringer Ingelheim Investigational Site
mi
from
Spartanburg, SC
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 6/1/2015
Boehringer Ingelheim Investigational Site
mi
from
Spartanburg, SC
Click here to add this to my saved trials
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated:  6/1/2015
Boehringer Ingelheim Investigational Site
mi
from
Houston, TX
Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)
Multi-center Open-label Expanded Access Program of Oral Nintedanib 150 mg Twice Daily in Patients With Idiopathic Pulmonary Fibrosis
Status: Enrolling
Updated: 6/1/2015
Boehringer Ingelheim Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Monitoring Chronic Obstructive Pulmonary Disease Patients at Home by a Forced Oscillation Technique Device
Monitoring COPD Patients at Home by a Forced Oscillation Technique Device
Status: Enrolling
Updated:  6/2/2015
Baylor College of Medicine
mi
from
Houston, Texas, TX
Monitoring Chronic Obstructive Pulmonary Disease Patients at Home by a Forced Oscillation Technique Device
Monitoring COPD Patients at Home by a Forced Oscillation Technique Device
Status: Enrolling
Updated: 6/2/2015
Baylor College of Medicine
mi
from
Houston, Texas, TX
Click here to add this to my saved trials
The Impact of Arousal Threshold in Obstructive Sleep Apnea
The Impact of Arousal Threshold in Obstructive Sleep Apnea: Donepezil's Effects on the Arousal Threshold and on the Apnea Hypopnea Index
Status: Enrolling
Updated:  6/4/2015
University of California, San Diego
mi
from
San Diego, CA
The Impact of Arousal Threshold in Obstructive Sleep Apnea
The Impact of Arousal Threshold in Obstructive Sleep Apnea: Donepezil's Effects on the Arousal Threshold and on the Apnea Hypopnea Index
Status: Enrolling
Updated: 6/4/2015
University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Status: Enrolling
Updated:  7/1/2015
BWH Division of Sleep Medicine
mi
from
Boston, MA
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Status: Enrolling
Updated: 7/1/2015
BWH Division of Sleep Medicine
mi
from
Boston, MA
Click here to add this to my saved trials
Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy Controls
Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy Controls
Status: Enrolling
Updated:  7/2/2015
Arkansas Children's Hospital
mi
from
Little Rock, AR
Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy Controls
Bone Microarchitecture at the Radius: a Pilot Comparison Between Children With Cystic Fibrosis and Healthy Controls
Status: Enrolling
Updated: 7/2/2015
Arkansas Children's Hospital
mi
from
Little Rock, AR
Click here to add this to my saved trials